Advance Agrolife Limited has announced a strategic land acquisition move through a Memorandum of Understanding with Bileshwar Pharmaceuticals Pvt. Ltd., marking a significant step in the company's expansion plans for pesticides manufacturing.

Land Acquisition Details

The company has entered into an MOU dated February 25, 2026, for acquiring land at the Dahej-II GIDC Industrial estate in District Bharuch, Gujarat. The acquisition involves a substantial land parcel that will serve as the foundation for the company's new manufacturing facility.

Manufacturing Facility Plans

The acquired land will be utilized to establish a new manufacturing plant specifically designed for the production of technical grade pesticides. This expansion aligns with the company's growth strategy in the agrochemicals sector and represents a significant investment in manufacturing capabilities.

Regulatory Compliance

Advance Agrolife Limited has fulfilled its disclosure obligations by informing both major stock exchanges about this development. The company has communicated this information to BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Future Updates

The company has indicated that it will provide additional information and updates regarding the project's progress in due course. Specifically, details about the date of commencement of commercial operations and other relevant developments will be shared with stakeholders as they become available. The intimation has also been made available on the company's official website at www.advanceagrolife.com for public access.

Advance Agrolife Limited has submitted its monitoring agency report on the utilization of IPO proceeds for the quarter ended December 31, 2025, in compliance with SEBI regulations. CARE Ratings Limited, serving as the monitoring agency, confirmed proper utilization of funds with no deviations from stated objectives.

IPO Proceeds Utilization Overview

The company raised ₹192.84 crore through its Initial Public Offering conducted from September 30, 2025, to October 03, 2025. During the quarter ended December 31, 2025, Advance Agrolife utilized ₹98.82 crore across designated objectives, leaving ₹94.02 crore unutilized.

Fund Deployment Across Objectives

The monitoring report details utilization across three primary objectives as outlined in the offer document:

Working Capital Utilization

Advance Agrolife deployed ₹67.50 crore for working capital requirements by transferring funds from the monitoring account to cash credit account. These funds were utilized for supplier payments for raw materials and statutory obligations, including advance tax payments.

General Corporate Purposes

The company utilized ₹8.16 crore towards capital expenditure as approved by the Board of Directors on October 29, 2025. The board resolution covered strategic initiatives, brand building, marketing activities, and capital expenditure requirements.

Deployment of Unutilized Proceeds

The remaining ₹94.02 crore has been strategically deployed in fixed deposits and bank accounts to optimize returns:

Regulatory Compliance and Monitoring

CARE Ratings Limited confirmed no deviations from the objects stated in the offer document. The monitoring agency verified utilization through chartered accountant certificates from S K Patodia & Associates LLP dated February 05, 2026, bank statements, and company declarations.

Company Secretary Nisha Gupta (A42708) digitally signed the regulatory filing on February 12, 2026, ensuring compliance with SEBI LODR Regulations. The report has been made available on the company's website at www.advanceagrolife.com for stakeholder access.

The monitoring report demonstrates Advance Agrolife's systematic approach to IPO proceeds utilization while maintaining regulatory compliance and transparency with stakeholders.